Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC15H14N4 |
InChIKeyNFBCSWGEYDCCDW-UHFFFAOYSA-N |
CAS Registry153436-70-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Discovery | GB | - |